VDAC1 and mesothelioma: The effects of silencing VDAC1 expression using si-m/hVDAC1-B on mesothelioma tumors were analyzed on established subcutaneous models of mesothelioma using human cells, NCI-H226, and an allogeneic mouse model using AB1 mouse cells.